{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:52:06Z","timestamp":1788839526587,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"IAEA \u2013 the International Atomic Energy Agency"},{"DOI":"10.13039\/100012526","name":"Faculty of Health Sciences, Aarhus University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012526","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIRRO"},{"DOI":"10.13039\/100007398","name":"Danish Council for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007398","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DAHANCA"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.radonc.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T12:35:55Z","timestamp":1429706155000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"116","clinical-trial-number":[{"clinical-trial-number":"nct01507467","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mohamed A.","family":"Hassan Metwally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maire","family":"Kuddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primoz","family":"Strojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.04.005_b0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2015.04.005_b0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2015.04.005_b0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1470-2045(10)70072-3","article-title":"Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial","volume":"11","author":"Overgaard","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1053-4296(96)80032-4","article-title":"Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers","volume":"6","author":"Overgaard","year":"1996","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0030","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(89)90917-6","article-title":"Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study","volume":"16","author":"Overgaard","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.04.005_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5\u201385","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0045","first-page":"S271","article-title":"Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide","volume":"27","author":"Saunders","year":"1996","journal-title":"Br J Cancer Suppl"},{"key":"10.1016\/j.radonc.2015.04.005_b0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semradonc.2004.04.002","article-title":"Clinical studies of hypoxia modification in radiotherapy","volume":"14","author":"Kaanders","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0055","first-page":"509","article-title":"Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors","volume":"6","author":"Overgaard","year":"1994","journal-title":"Oncol Res"},{"key":"10.1016\/j.radonc.2015.04.005_b0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck\u2013a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clon.2007.03.010","article-title":"Chemical radiosensitizers for use in radiotherapy","volume":"19","author":"Wardman","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2015.04.005_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0167-8140(91)90202-R","article-title":"Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5\u201385","volume":"20","author":"Overgaard","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/0284186X.2013.864050","article-title":"Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)","volume":"53","author":"Metwally","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0080","unstructured":"DAHANCA. DAHANCA. 2-4-2015. <http:\/\/www.dahanca.dk\/>."},{"key":"10.1016\/j.radonc.2015.04.005_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-8140(03)00020-3","article-title":"Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial","volume":"67","author":"Grau","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0090","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2015.04.005_b0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2011.09.010","article-title":"Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck","volume":"102","author":"Toustrup","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0100","author":"Intergroup Study (EORTC-1219-ROG-HNCG \u2013 DAHANCA-29):","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2015.04.005_b0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2015.04.005_b0110","author":"Sobin","year":"2009"},{"key":"10.1016\/j.radonc.2015.04.005_b0115","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v3.0. NCI. 3-10-2014. <http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications>."},{"key":"10.1016\/j.radonc.2015.04.005_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2012.09.017","article-title":"Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression","volume":"105","author":"Lassen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bjc.1983.153","article-title":"Studies of the pharmacokinetic properties of nimorazole","volume":"48","author":"Overgaard","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2015.04.005_b0130","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/0360-3016(84)90545-5","article-title":"A phase I clinical study of Nimorazole as a hypoxic radiosensitizer","volume":"10","author":"Timothy","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.04.005_b0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clon.2014.11.024","article-title":"Study of the population pharmacokinetic characteristics of Nimorazole in head and neck cancer patients treated in the DAHANCA-5 Trial","volume":"27","author":"Hassan Metwally","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2015.04.005_b0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-014-3459-7","article-title":"Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983\u20132009: role of human papillomavirus infection","author":"Strojan","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.radonc.2015.04.005_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2009.10.008","article-title":"HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer","volume":"94","author":"Lassen","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/02841860310004364","article-title":"Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer\u2013a review of their cooperation","volume":"42","author":"Marcu","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/jjco\/hyr086","article-title":"Concomitant weekly cisplatin and radiotherapy for head and neck cancer","volume":"41","author":"Homma","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-8140(88)90225-3","article-title":"Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay","volume":"13","author":"Grau","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0175","first-page":"1","article-title":"Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study","author":"Bentzen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.04.005_b0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clon.2014.03.003","article-title":"NIMRAD \u2013 a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer","volume":"26","author":"Thomson","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015001929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015001929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T04:22:03Z","timestamp":1589516523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015001929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0167814015001929"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.04.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}